These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3652706)

  • 21. Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery.
    Cai J; Su Z; Zhou Y; Shi Z; Xu Z; Liu J; Xu Z; Yang Y
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):557-62. PubMed ID: 21371901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First intention high-frequency oscillatory and conventional mechanical ventilation in premature infants without antenatal glucocorticoid prophylaxis.
    Salvo V; Zimmermann LJ; Gavilanes AW; Barberi I; Ricotti A; Abella R; Frigiola A; Giamberti A; Florio P; Tagliabue P; Tina LG; Nigro F; Temporini F; Gazzolo D
    Pediatr Crit Care Med; 2012 Jan; 13(1):72-9. PubMed ID: 21499177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment.
    Dunn MS; Shennan AT; Zayack D; Possmayer F
    Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial.
    Vento G; Pastorino R; Boni L; Cota F; Carnielli V; Cools F; Dani C; Mosca F; Pillow J; Polglase G; Tagliabue P; van Kaam AH; Ventura ML; Tana M; Tirone C; Aurilia C; Lio A; Ricci C; Gambacorta A; Consigli C; D'Onofrio D; Gizzi C; Massenzi L; Cardilli V; Casati A; Bottino R; Pontiggia F; Ciarmoli E; Martinelli S; Ilardi L; Colnaghi M; Matassa PG; Vendettuoli V; Villani P; Fusco F; Gazzolo D; Ricotti A; Ferrero F; Stasi I; Magaldi R; Maffei G; Presta G; Perniola R; Messina F; Montesano G; Poggi C; Giordano L; Roma E; Grassia C; Ausanio G; Sandri F; Mescoli G; Giura F; Garani G; Solinas A; Lucente M; Nigro G; Del Vecchio A; Petrillo F; Orfeo L; Grappone L; Quartulli L; Scorrano A; Messner H; Staffler A; Gargano G; Balestri E; Nobile S; Cacace C; Meli V; Dallaglio S; Pasqua B; Mattia L; Gitto E; Vitaliti M; Re MP; Vedovato S; Grison A; Berardi A; Torcetta F; Guidotti I; di Fabio S; Maranella E; Mondello I; Visentin S; Tormena F
    Trials; 2016 Aug; 17():414. PubMed ID: 27538798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.
    Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation.
    Kattwinkel J; Bloom BT; Delmore P; Davis CL; Farrell E; Friss H; Jung AL; King K; Mueller D
    Pediatrics; 1993 Jul; 92(1):90-8. PubMed ID: 8516091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors influencing the clinical response to surfactant replacement therapy in babies with severe respiratory distress syndrome. Collaborative European Multicentre Study Group.
    Eur J Pediatr; 1991 Apr; 150(6):433-9. PubMed ID: 2040354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of surfactant administration in neonates with respiratory distress syndrome. II. Radiographic changes].
    Gadzinowski J; Halliday H; Szymankiewicz M; Rzymska I; Solawa M
    Ginekol Pol; 1992 Aug; 63(8):373-6. PubMed ID: 1304522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of INSURE method with conventional mechanical ventilation after surfactant administration in preterm infants with respiratory distress syndrome: therapeutic challenge.
    Nayeri FS; Esmaeilnia Shirvani T; Aminnezhad M; Amini E; Dalili H; Moghimpour Bijani F
    Acta Med Iran; 2014; 52(8):596-600. PubMed ID: 25149882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
    Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
    J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of surfactant for prevention of respiratory distress syndrome in newborn infants in spontaneous breathing. A randomized multicentre clinical pilot-study.
    Dambeanu JM; Parmigiani S; Marinescu B; Bevilacqua G
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():39-45. PubMed ID: 10021716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe neonatal respiratory distress syndrome treated with the isolated phospholipid fraction of natural surfactant.
    Noack G; Berggren P; Curstedt T; Grossmann G; Herin P; Mortensson W; Nilsson R; Robertson B
    Acta Paediatr Scand; 1987 Sep; 76(5):697-705. PubMed ID: 3661171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.
    Göpel W; Kribs A; Ziegler A; Laux R; Hoehn T; Wieg C; Siegel J; Avenarius S; von der Wense A; Vochem M; Groneck P; Weller U; Möller J; Härtel C; Haller S; Roth B; Herting E;
    Lancet; 2011 Nov; 378(9803):1627-34. PubMed ID: 21963186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory distress syndrome treated with human surfactant: radiographic findings.
    Edwards DK; Hilton SV; Merritt TA; Hallman M; Mannino F; Boynton BR
    Radiology; 1985 Nov; 157(2):329-34. PubMed ID: 3840268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surfactant replacement therapy.
    Stevens TP; Sinkin RA
    Chest; 2007 May; 131(5):1577-82. PubMed ID: 17494810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [X-ray findings and clinical analysis for newborn infants with neonatal respiratory distress syndrome].
    Zhao ZM; Yang L; Cui B
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 32(6):1069-74. PubMed ID: 18182729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective randomized multicenter comparison of high-frequency oscillatory ventilation and conventional ventilation in preterm infants of less than 30 weeks with respiratory distress syndrome.
    Moriette G; Paris-Llado J; Walti H; Escande B; Magny JF; Cambonie G; Thiriez G; Cantagrel S; Lacaze-Masmonteil T; Storme L; Blanc T; Liet JM; André C; Salanave B; Bréart G
    Pediatrics; 2001 Feb; 107(2):363-72. PubMed ID: 11158471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery.
    Pinheiro JM; Santana-Rivas Q; Pezzano C
    J Perinatol; 2016 Mar; 36(3):196-201. PubMed ID: 26633145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.